Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.3018
Abstract: 3018Background: With FDA approval of three novel agents targeting the PD-L1/PD-1 checkpoint pathway in multiple tumor types, use of these agents in the clinical setting is becoming increasingly common. However, little is published on their…
read more here.
Keywords:
immunotherapy agents;
autoimmune diseases;
diseases treated;
treated immunotherapy ... See more keywords